Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts

FEBS Lett. 1988 Aug 15;236(1):47-52. doi: 10.1016/0014-5793(88)80283-7.


Tumor necrosis factor (TNF) caused inhibition of collagen production by confluent cultures of human dermal fibroblasts in a dose-dependent manner. Concomitant increase of prostaglandin E2 release was observed as a result of TNF-induced cell activation. However, a blockade of the cyclooxygenase pathway of arachidonate metabolism by indomethacin did not abrogate the inhibitory effect of TNF on collagen synthesis, suggesting that this effect could be independent of prostaglandin metabolism. Gel electrophoresis of the newly synthesized macromolecules from the culture media showed that both type I and type III collagens as well as fibronectin were affected by the inhibition. Electrophoresis of cell layer-associated proteins demonstrated that the reduction in amounts of collagen and fibronectin in the medium did not result from an intracellular accumulation of these macromolecules. Production of procollagens was reduced in parallel to that of collagens, suggesting that the effect of TNF is exerted before the processing steps of procollagens. These results clearly show that TNF could play a role in modulation of matrix deposition by fibroblasts during inflammatory processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division
  • Cells, Cultured
  • Collagen / biosynthesis*
  • Dinoprostone
  • Electrophoresis, Polyacrylamide Gel
  • Fibroblasts
  • Fibronectins / biosynthesis*
  • Humans
  • Indomethacin / pharmacology
  • Prostaglandins E / biosynthesis
  • Recombinant Proteins / pharmacology
  • Skin / cytology
  • Skin / drug effects*
  • Skin / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology*


  • Fibronectins
  • Prostaglandins E
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Collagen
  • Dinoprostone
  • Indomethacin